Lyons Jeri A, Riter Melissa M, Almatrook Alaa M, Ramsbottom Michael J, Cross Anne H
Department of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI 53211, USA; Department of Neurology and Neurosurgery, Washington University School of Medicine, Saint Louis, MO, USA 63110.
Department of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI 53211, USA.
J Neuroimmunol. 2016 Nov 15;300:66-73. doi: 10.1016/j.jneuroim.2016.06.006. Epub 2016 Jun 24.
Previous work demonstrated that EAE induced by recombinant human MOG was B cell-dependent. Data presented here reveal a T cell response to MOG61-85 in human rMOG-immunized B cell mice not observed in WT mice. Further study revealed this peptide to be a cryptic epitope in WT mice. Co-immunization of B cell mice with MOG35-55 and MOG61-85 peptides led to less severe disease compared to mice immunized with MOG35-55 alone. Disease amelioration was associated with decreased production of Interferon-γ by lymph node cells. Thus, MOG61-85 represents a protective epitope to human rMOG induced EAE in B cell mice.
先前的研究表明,重组人髓鞘少突胶质细胞糖蛋白(MOG)诱导的实验性自身免疫性脑脊髓炎(EAE)依赖于B细胞。此处呈现的数据显示,在用人重组MOG免疫的B细胞小鼠中可观察到针对MOG61 - 85的T细胞反应,而在野生型(WT)小鼠中未观察到。进一步研究表明,该肽段在WT小鼠中是一个隐蔽表位。与单独用MOG35 - 55免疫的小鼠相比,用MOG35 - 55和MOG61 - 85肽段共同免疫B细胞小鼠导致的疾病症状较轻。疾病改善与淋巴结细胞产生的γ干扰素减少有关。因此,MOG61 - 85代表了在B细胞小鼠中对人重组MOG诱导的EAE具有保护作用的表位。